[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
e-biomed: the journal of regenerative medicine, online only journal launches with 8 papers free to view
- To: "'liblicense-l@lists.yale.edu'" <liblicense-l@lists.yale.edu>
- Subject: e-biomed: the journal of regenerative medicine, online only journal launches with 8 papers free to view
- From: "Mulak, Tom" <TMulak@liebertpub.com>
- Date: Tue, 7 Mar 2000 19:58:17 EST
- Reply-To: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
For Immediate Release Contact: Christopher Dauer (914) 834-3100, ext. 613; cdauer@liebertpub.com e-biomed: the journal of regenerative medicine Launches, Exclusively Online March 7, 2000 Larchmont, NY - A new peer-reviewed electronic journal entitled e-biomed: the journal of regenerative medicine has been published, focusing on a unique approach to healing-the regeneration of organs, tissues, and cells. To facilitate advances in this exciting new field, "papers will be published electronically, immediately upon acceptance," said Mary Ann Liebert, president of Mary Ann Liebert, Inc. (www.liebertpub.com <http://www.bioconferences.com> .) Connect to www.liebertpub.com/reg <http://www.liebertpub.com/reg> to view, at no cost, the first 8 papers. "The implications of renewing body tissues with the help of natural signals that control its growth are enormous," said the Journal's editor-in-chief, William A. Haseltine, Ph.D., who has coined the term "regenerative medicine" to signify this promising area of research endeavor. "As we understand the body's repair process at the genetic level," Dr. Haseltine said, "we will be able to advance the goal of maintaining our bodies in normal function, perhaps perpetually." Dr. Haseltine is the Chairman and CEO of Human Genome Sciences, a Maryland biotechnology company (NASDAQ: HGSI). The Journal has an outstanding and diverse editorial board of 100 leaders in different disciplines, including Robert Langer, W. French Anderson, Jeffrey Isner, R. Michael Blaese, Judith Campisi, and Gary Nabel. The inaugural issue includes papers on Tissue Engineering: Status and Challenges; Transplantation Therapies from Human Embryonic Stem Cell-Circumventing Immune Rejection; and Regenerative Biology of Hearing: Taking the Breaks Off the Cell Cycle Engine. The manuscript submission and peer-review process of the Journal is strictly electronic, with papers available on-line to subscribers within three weeks of acceptance. Enrollees in Liebert Alert, the free table of contents alerting service, will automatically be sent an e-mail notification that a new article has been published. The on-line Journal is available in a variety of formats, including PDF, for use with Adobe Reader. Papers are fully searchable by key word or phrase, plain text, abstract only, etc. The reference citations are hyperlinked to external bibliographic resources on the Internet such as Medline, Cambridge Scientific Abstracts, and IFI's Web of Science. Mary Ann Liebert, Inc. is an independent publisher of cutting-edge biomedical journals, books and newsletters, with leading publications including Genetic Engineering News, Human Gene Therapy, Cloning, Microbial & Comparative Genomics, Tissue Engineering, and many more. For more information or to subscribe to e-biomed, visit www.liebertpub.com/reg <http://www.liebertpub.com/reg>
- Prev by Date: Elsevier web journals
- Next by Date: UK Serials Group Conference 2000 and Exhibition
- Prev by thread: UK Serials Group Conference 2000 and Exhibition
- Next by thread: Elsevier web journals
- Index(es):